‘Hot mess’: Abortion pills at pharmacies could face legal quagmires, especially in restrictive states
WASHINGTON — Federal regulators’ green light for pharmacists to dispense abortion pills is crashing into…
Author: STAT
HHS needs better oversight of research that alters pathogens, government watchdog says
WASHINGTON — The health department’s oversight of research that could enhance dangerous pathogens has vague…
Mental health benefits of gender-affirming hormones for teens persist for two years in new study
Trans and nonbinary teenagers who receive gender-affirming hormones experience less depression and anxiety and more…
STAT+: Verily leans into Onduo as it looks to enter the lucrative world of running medical research
The new, streamlined Verily will have one very recognizable component: its virtual care company Onduo,…
HIV vaccine being developed by Johnson & Johnson fails clinical trial
Yet another experimental HIV vaccine has failed. The National Institute of Allergy and Infectious Diseases…
Opinion: Leaders at Davos need to pay attention to the crossroads of climate change, health, and security
As CEOs and world leaders gather for the World Economic Forum in Davos, Switzerland, this…
STAT+: Pharmalittle: HIV vaccine study is stopped early; Merck has a plan to combat carcinogen found in diabetes drugs
Top of the morning to you. The middle of the week is upon us and,…
STAT+: Hip and knee replacements go better when performed by high-volume surgeons, new study finds
A new study underscores the importance of the adage “practice makes perfect,” especially when it…
U.S. plans crackdown on nursing homes that sedate patients with unnecessary antipsychotics
WASHINGTON (AP) — The federal government says it will begin a targeted crackdown on nursing…
Opinion: Biopharma leaders helped save democracy. Now what?
The rule of law must be upheld for free societies and free markets to flourish,…
In the search for therapies for solid tumors, companies are turning to a novel target: claudin-6
On Target is a recurring feature from STAT that dives deep into the most promising…
Mix-it-yourself Wegovy? Some are trying risky sources for weight-loss drugs
With a few clicks, Daniel added the chemical to his online cart and ordered it….
STAT+: Major purchasers predict expensive new therapies will keep driving drug price hikes
More than two dozen big buyers of prescription medicines expect that prices will rise by…
STAT+: Moderna says RSV vaccine worked, setting stage for competition with GSK and Pfizer
Moderna’s vaccine against the respiratory syncytial virus, or RSV, reduced the rate of lower respiratory…
STAT+: After four years of big talk, mega startup Sana prepares to deliver some data
SAN FRANCISCO — The last time Sana CEO Steve Harr was here for the J.P….
STAT+: Pfizer says it will widen access to hundreds of off-patent medicines in poor countries
In another bid to widen access to its medical products, Pfizer plans to provide roughly…
STAT+: Pharmalittle: Lilly and AbbVie exit U.K. drug-pricing program; J&J scales back Covid-19 vaccine production
Good morning, everyone, and welcome to another working week, which is only getting started on…
STAT+: Large health insurers lowered barriers to fair access to some drugs, analysis finds
Most of the largest health plans in the U.S. generally provide “fair access” to 19…
.jpg)
Opinion: STAT+: 4 concrete steps to realize the AI Bill of Rights for clinical decision support software
The Blueprint for an AI Bill of Rights the White House recently published didn’t come…
The addiction crisis is causing a spike in endocarditis cases. Hospitals are struggling to respond
Increased injection drug use has led to a spike in cases of the life-threatening heart…
Opinion: Stop blaming Biogen for putting profit at the expense of patients. Blame the systems that enabled it
Two congressional committees recently released damning results of an 18-month investigation into the Food and…
STAT+: Hospitals gear up to expand market power, raise prices in 2023
SAN FRANCISCO — More than a dozen of the country’s large not-for-profit hospital systems descended…
Telehealth patients are scrambling for in-person care amid crackdown on online controlled substances
Catherine was getting nervous about her ADHD prescription. In 2022, the 29-year-old New Yorker had…
STAT+: Liquid biopsy study suggests a better way to decide which colorectal cancer patients need chemo
They’re far too small to be seen by even the most sophisticated medical imaging device….
STAT+: Invitae’s new CEO on why the genetic testing firm stopped chasing ‘volume at all costs’
SAN FRANCISCO — Invitae, a Bay Area genetic testing company with a mission to use…
STAT+: Congressional Medicare advisers warn of higher drug prices, despite new price negotiation
WASHINGTON — Despite the pharmaceutical industry’s loud complaints to the contrary, the new law directing…
Biden Covid adviser David Kessler to exit as pandemic response winds down
WASHINGTON — David Kessler, the D.C. veteran who guided government dispatches of millions of Covid-19…
STAT+: Q&A with Carbon Health’s Myoung Cha: Why the company is changing course
SAN FRANCISCO — Carbon Health is in a turbulent time: The primary care tech company…
Virtual Event: “JPM Recap, Live!” 2023
Editor’s Note: A live stream of the event will be embedded below at 1:00 PM…
STAT+: Pharmalittle: Pharma prioritizes biologics over pills due to drug-pricing law; former Takeda employee accused of creating fake consulting firm
And so, another working week will soon draw to a close. Not a moment too…
STAT+: Loan repayment program seeks to bolster infectious disease field
As part of the $1.7 trillion government spending bill that President Biden signed late last…
Opinion: For addiction treatment, longer is better. But insurance companies usually cut it short
Access to treatment for addiction has long plagued U.S. health systems. Why? Two reasons: It…
STAT+: Oscar Health’s CEO on post-hype health insurance and finally turning a profit
Oscar Health has excelled at one thing in particular since its inception a decade ago:…
STAT+: As Ginkgo stock sinks, CEO Jason Kelly tries to win over drugmakers in San Francisco
SAN FRANCISCO — Ginkgo Bioworks CEO Jason Kelly is here trying to convince the world’s…
STAT+: Biotech startups are hungry for dollars. Here’s what one pharma executive was looking for at JPM
Marianne De Backer’s iPhone calendar is a solid block of green. De Backer, the head…
STAT+: With the FTC’s more expansive approach to antitrust, PBMs are in the crosshairs
WASHINGTON — The Democrats leading the Federal Trade Commission are hoping to expand the agency’s…
STAT+: California is the latest state to sue drugmakers and PBMs over insulin pricing
The California attorney general has filed a lawsuit accusing several drugmakers and pharmacy benefit managers…
‘We become millionaires and we retire babe’: Former Takeda worker and boyfriend accused of $2.3 million scam of drug firm
A high-ranking former technology officer at Takeda Pharmaceutical’s US headquarters in Massachusetts and her boyfriend…
STAT+: Regeneron executive George Yancopoulos admits some regret, but ‘I don’t apologize’
SAN FRANCISCO — George Yancopoulos isn’t apologizing. The president and chief scientist of Regeneron was…
Opinion: More nurses: The smart way to save lives, money — and nurses
Although the 7,000 New York City nurses who went on strike this week reached a…
Routine vaccinations drop among U.S. kindergartners for the third year in a row
The percentage of U.S. kindergartners who’ve received standard childhood vaccines took a small but notable…
#JPM23 in review, the year ahead, & the merits of Miami
What happened at biotech’s big reunion? Will this year be better than the last? And…
Opinion: A lesson from JPM: Too many digital front doors in health care lead to nowhere
Top health care leaders braved rain, hail, and flash flood warnings at this year’s J.P….
STAT+: Pharmalittle: HHS readying details for Medicare drug-price negotiations; doctors urge FDA to hold expert meeting before approving Alzheimer’s drug
Top of the morning to you. Gray skies are hovering over the Pharmalot campus right…
Opinion: Democratizing drug development will be a win for all
In 1992, the film Lorenzo’s Oil celebrated the true story of two parents who, despite…
Medical schools are missing the mark on artificial intelligence
Ready or not, health care is undergoing a massive transformation driven by artificial intelligence. But…
STAT+: BioNTech CEO lays out vision for how mRNA and AI can power personalized medicine
SAN FRANCISCO — When BioNTech was founded in 2008, messenger RNA therapies and vaccines were…
XB what? BQ huh? Do you need to keep up with Omicron’s ever-expanding offspring?
It’s like clockwork now. Every few months, we’re warned that the Omicron variant of the…
STAT+: Medicare paves the way for CAR-T in doctors offices
WASHINGTON — Medicare officials have taken a step toward making a cutting-edge cancer treatment called…
STAT+: Drastic changes should bring profitability, startup health insurers say
Startup insurers Oscar Health, Bright Health, and Clover Health have hemorrhaged money since going public…